Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

EW-A-401 studied for critical limb ischemia

June 29, 2005

YM-281956: A novel orally bioavailable NCX inhibitor

June 29, 2005

BiDil approved for treatment of heart failure in black patients

June 28, 2005

Recent patents describe novel agents for cardiovascular diseases

June 28, 2005

Enrollment begins in SPIRIT III study of Xience V stent

June 28, 2005

Long-term benefits of atorvastatin in patients with type 2 diabetes

June 27, 2005

FDA extends action date for Aceon sNDA review

June 23, 2005

Issues raised during European review of Endeavor drug-eluting coronary stent

June 22, 2005

Recordati buys back U.K. rights to Zanidip

June 22, 2005

VALOR study of Talent thoracic stent graft system

June 21, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...